Difficulty: Medium
Average Score: 77%
Practice
After seven days of treatment with sulfonamides a patient's haemoglobin had decreased from 14.7 gm/100 ml to 10 gm/100 ml. The most likely cause of hemolysis in this patient is
Correct answer
D
Rationale
In this case, the correct answer is D) Glucose 6-phosphate dehydrogenase deficiency (G6PD).
G6PD deficiency is an inherited condition that leads to red blood cell destruction (hemolysis) when the cells are exposed to certain triggers like sulfonamide drugs. Sulfonamides can induce oxidative stress in red blood cells, and in individuals with G6PD deficiency, the cells are unable to defend against this stress, leading to hemolysis.
Option A) Sickle cell disease is an inherited disorder characterized by abnormal hemoglobin that causes the red blood cells to become rigid and form a sickle shape. While sickle cell disease can lead to anemia, it is not directly related to the mechanism of action of sulfonamides causing hemolysis in G6PD deficiency.
Option B) Thalassemia minor is a genetic disorder affecting the production of hemoglobin, leading to anemia. However, it does not predispose individuals to hemolysis triggered by sulfonamides as in G6PD deficiency.
Option C) Hereditary spherocytosis is a condition characterized by abnormal red blood cells that are spherical in shape. While this condition can also lead to hemolysis, it is not directly linked to the mechanism of sulfonamide-induced hemolysis seen in G6PD deficiency.
Educational Context:
Understanding the interactions between drugs and the hematological system is crucial in clinical practice. Recognizing the potential adverse effects of medications in patients with specific genetic conditions like G6PD deficiency can help healthcare providers make informed decisions to prevent harm. This case highlights the importance of knowing the underlying pathophysiology of hemolysis in different conditions to provide safe and effective patient care.
G6PD deficiency is an inherited condition that leads to red blood cell destruction (hemolysis) when the cells are exposed to certain triggers like sulfonamide drugs. Sulfonamides can induce oxidative stress in red blood cells, and in individuals with G6PD deficiency, the cells are unable to defend against this stress, leading to hemolysis.
Option A) Sickle cell disease is an inherited disorder characterized by abnormal hemoglobin that causes the red blood cells to become rigid and form a sickle shape. While sickle cell disease can lead to anemia, it is not directly related to the mechanism of action of sulfonamides causing hemolysis in G6PD deficiency.
Option B) Thalassemia minor is a genetic disorder affecting the production of hemoglobin, leading to anemia. However, it does not predispose individuals to hemolysis triggered by sulfonamides as in G6PD deficiency.
Option C) Hereditary spherocytosis is a condition characterized by abnormal red blood cells that are spherical in shape. While this condition can also lead to hemolysis, it is not directly linked to the mechanism of sulfonamide-induced hemolysis seen in G6PD deficiency.
Educational Context:
Understanding the interactions between drugs and the hematological system is crucial in clinical practice. Recognizing the potential adverse effects of medications in patients with specific genetic conditions like G6PD deficiency can help healthcare providers make informed decisions to prevent harm. This case highlights the importance of knowing the underlying pathophysiology of hemolysis in different conditions to provide safe and effective patient care.